ArtuVet is an innovative pharmaceutical company and is market leader in allergen-specific immunotherapy. ArtuVet has accumulated a wealth of experience and knowledge in the field of diagnostics and the treatment of allergies.
The drugs that ArtuVet develops and manufactures focus on the underlying cause of the allergy. As a result, the long-term effect, i.e. significant reduction of the allergy symptoms and prevention of further progression of the condition, is guaranteed.
Artuvetrin® is the only registered immunotherapy for dogs. The Artuvetrin® products are used both in the Netherlands and in countries worldwide. ArtuVet has key account managers in Sweden United Kingdom and the Netherlands